TY - JOUR T1 - Dr. Roll, <em>et al</em> reply JF - The Journal of Rheumatology JO - J Rheumatol SP - 203 LP - 203 DO - 10.3899/jrheum.121365 VL - 40 IS - 2 AU - PETRA ROLL AU - THOMAS DÖRNER AU - HANS TONY Y1 - 2013/02/01 UR - http://www.jrheum.org/content/40/2/203.2.abstract N2 - To the Editor:We thank Drs. Besada and Nossent for their remarks regarding the rate of serious infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) treated with rituximab1. Their points are well taken, and more studies on this topic are required in the future. Clearly, … Address correspondence to Dr. P. Roll, Department of Rheumatology/Clinical Immunology, University of Würzburg, Oberdürrbacher Str. 6, Würzburg 97080, Germany. E-mail: Roll_P{at}klinik.uni-wuerzburg.de ER -